← All news
Markets

Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript

1 source ·2 articles ·Aug 20, 01:31 UTC Tetra Technologies Tvardi Therapeutics

Covered by 1 outlet

All coverage · 2 articles